Enrofloxacin Market Growth Accelerated by Rising Livestock Disease Prevalence
Enrofloxacin is a broad-spectrum fluoroquinolone antimicrobial agent used for the treatment of bacterial infections in various livestock such as cattle, pigs, and poultry. It provides effective treatment for respiratory and enteric infections caused by Gram-positive and Gram-negative bacteria. The global enrofloxacin market is estimated to be valued at US$ 470.4 Mn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The rising prevalence of livestock diseases globally is one of the major factors fueling the growth of the enrofloxacin market. According to the Food and Agriculture Organization (FAO), livestock diseases lead to 20-40% losses in livestock production every year. Furthermore, changing outbreak patterns of diseases and emergence of new pathogens continue to threaten livestock health and productivity. For instance, in 2018, African swine fever caus...